retatrutide micro dosing Dosage: Titration Schedule Understanding the Retatrutide starting dose

Platelet biomarkers identifying mild cognitive impairment in type 2 diabetes patients

Looking Ahead One of the big unanswered questions with GLP-1 therapy is what happens when patients stop taking the medication

For Lilly internally, retatrutide moves from a hopeful pipeline asset to a pillar of the company's late-decade franchise alongside tirzepatide, which still dominates the dual-agonist segment, and oral orforglipron, which has its own ATTAIN-1 data showing 12.4% loss in non-diabetic adults

Wat zijn de voordelen van L-carnitine

GLP-1s are serious medications with certain potential toxicities for some patients, including pancreatitis, thyroid cancer, and very rarely, but now officially acknowledged in the case of Wegovy blindness, caused by a condition called non-arteritic anterior ischemic optic neuropathy (NAION)

David Amron